

20 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-results-of-the-empress-study-show-the-activity-of-giredestrant-in-reducing-tumor-proliferation-in-erher2--breast-cancer-at-early-stages-without-the-need-for-ovarian-function-suppression-302588871.html

18 Oct 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/esmo-roche-wants-oral-serd-benefit-all-comers-unveils-phase-3-breast-cancer-data

13 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/13/3165275/0/en/Roche-data-at-ESMO-2025-showcase-advances-in-science-and-cancer-care-across-multiple-tumour-types.html

24 Sep 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/roche-reports-phase-3-breast-cancer-victory-starting-key-period-oral-serd-win